Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype - PubMed (original) (raw)
Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype
G Millat et al. Am J Hum Genet. 1999 Nov.
Abstract
Niemann-Pick type C (NPC) disease is an autosomal recessive lipid-storage disorder usually characterized by hepatosplenomegaly and severe progressive neurological dysfunction, resulting from mutations affecting either the NPC1 gene (in 95% of the patients) or the yet-to-be-identified NPC2 gene. Our initial study of 25 patients with NPC1 identified a T3182-->C transition that leads to an I1061T substitution in three patients. The mutation, located in exon 21, affects a putative transmembrane domain of the protein. PCR-based tests with genomic DNA were used to survey 115 unrelated patients from around the world with all known clinical and biochemical phenotypes of the disease. The I1061T allele constituted 33 (14.3%) of the 230 disease-causing alleles and was never found in controls (>200 alleles). The mutation was particularly frequent in patients with NPC from Western Europe, especially France (11/62 alleles) and the United Kingdom (9/32 alleles), and in Hispanic patients whose roots were in the Upper Rio Grande valley of the United States. The I1061T mutation originated in Europe and the high frequency in northern Rio Grande Hispanics results from a founder effect. All seven unrelated patients who were homozygous for the mutation and their seven affected siblings had a juvenile-onset neurological disease and severe alterations of intracellular LDL-cholesterol processing. The mutation was not found (0/40 alleles) in patients with the severe infantile neurological form of the disease. Testing for this mutation therefore has important implications for genetic counseling of families affected by NPC.
Figures
Figure 1
Sequence of NPC1 exon 21 with intron boundaries, depicting the location of the T3182→C transition and the design of primers for detection of the mutation by creation of a Rsa I restriction site. Intronic sequences are in lowercase characters; exonic sequences are in uppercase.The asterisk (*) indicates the base change made in the forward primer to introduce a _Rsa_I restriction site when the adjacent T→C base change is present.
Figure 2
Restriction analysis of the I1061T mutation in a representative family. In presence of the mutation, Rsa I digestion of the 147-bp PCR product generates a 122-bp fragment. The results presented are those in family 1 (see table 3). Mk indicates molecular-mass DNA marker (100 and 200 bp); Fa, father; Mo, mother; P1, P2, P3, P4, affected siblings; Contr, normal subject. The plus sign (+) denotes the presence of a I1061T allele; the minus sign (−) denotes its absence.
Similar articles
- Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop.
Millat G, Marçais C, Tomasetto C, Chikh K, Fensom AH, Harzer K, Wenger DA, Ohno K, Vanier MT. Millat G, et al. Am J Hum Genet. 2001 Jun;68(6):1373-85. doi: 10.1086/320606. Epub 2001 May 1. Am J Hum Genet. 2001. PMID: 11333381 Free PMC article. - Niemann-Pick type C disease: NPC1 mutations associated with severe and mild cellular cholesterol trafficking alterations.
Ribeiro I, Marcão A, Amaral O, Sá Miranda MC, Vanier MT, Millat G. Ribeiro I, et al. Hum Genet. 2001 Jul;109(1):24-32. doi: 10.1007/s004390100531. Hum Genet. 2001. PMID: 11479732 - Identification of 58 novel mutations in Niemann-Pick disease type C: correlation with biochemical phenotype and importance of PTC1-like domains in NPC1.
Park WD, O'Brien JF, Lundquist PA, Kraft DL, Vockley CW, Karnes PS, Patterson MC, Snow K. Park WD, et al. Hum Mutat. 2003 Oct;22(4):313-25. doi: 10.1002/humu.10255. Hum Mutat. 2003. PMID: 12955717 - Niemann-Pick disease type C.
Liscum L, Klansek JJ. Liscum L, et al. Curr Opin Lipidol. 1998 Apr;9(2):131-5. doi: 10.1097/00041433-199804000-00009. Curr Opin Lipidol. 1998. PMID: 9559270 Review. - Niemann-Pick C disease: cholesterol handling gone awry.
Morris JA, Carstea ED. Morris JA, et al. Mol Med Today. 1998 Dec;4(12):525-31. doi: 10.1016/s1357-4310(98)01374-4. Mol Med Today. 1998. PMID: 9866822 Review.
Cited by
- Sterol O-Acyltransferase 1 (SOAT1): A Genetic Modifier of Niemann-Pick Disease, Type C1.
Farhat NY, Alexander D, McKee K, Iben J, Rodriguez-Gil JL, Wassif CA, Cawley NX, Balch WE, Porter FD. Farhat NY, et al. Int J Mol Sci. 2024 Apr 11;25(8):4217. doi: 10.3390/ijms25084217. Int J Mol Sci. 2024. PMID: 38673803 Free PMC article. - The Genetic Basis, Lung Involvement, and Therapeutic Options in Niemann-Pick Disease: A Comprehensive Review.
Tirelli C, Rondinone O, Italia M, Mira S, Belmonte LA, De Grassi M, Guido G, Maggioni S, Mondoni M, Miozzo MR, Centanni S. Tirelli C, et al. Biomolecules. 2024 Feb 11;14(2):211. doi: 10.3390/biom14020211. Biomolecules. 2024. PMID: 38397448 Free PMC article. Review. - At a glance: the largest Niemann-Pick type C1 cohort with 602 patients diagnosed over 15 years.
Guatibonza Moreno P, Pardo LM, Pereira C, Schroeder S, Vagiri D, Almeida LS, Juaristi C, Hosny H, Loh CCY, Leubauer A, Torres Morales G, Oppermann S, Iurașcu MI, Fischer S, Steinicke TM, Viceconte N, Cozma C, Kandaswamy KK, Pinto Basto J, Böttcher T, Bauer P, Bertoli-Avella A. Guatibonza Moreno P, et al. Eur J Hum Genet. 2023 Oct;31(10):1108-1116. doi: 10.1038/s41431-023-01408-7. Epub 2023 Jul 11. Eur J Hum Genet. 2023. PMID: 37433892 Free PMC article. - A differential proteomics study of cerebrospinal fluid from individuals with Niemann-Pick disease, Type C1.
Li W, Pergande MR, Crutchfield CA, Searle BC, Backlund PS, Picache JA, Burkert K, Yanjanin-Farhat NM, Blank PS, Toth CL, Wassif CA, Porter FD, Cologna SM. Li W, et al. Proteomics. 2023 Jun;23(11):e2200378. doi: 10.1002/pmic.202200378. Epub 2023 Jan 26. Proteomics. 2023. PMID: 36638187 Free PMC article. - Activation of mitochondrial TRAP1 stimulates mitochondria-lysosome crosstalk and correction of lysosomal dysfunction.
Chen FW, Davies JP, Calvo R, Chaudhari J, Dolios G, Taylor MK, Patnaik S, Dehdashti J, Mull R, Dranchack P, Wang A, Xu X, Hughes E, Southall N, Ferrer M, Wang R, Marugan JJ, Ioannou YA. Chen FW, et al. iScience. 2022 Aug 14;25(9):104941. doi: 10.1016/j.isci.2022.104941. eCollection 2022 Sep 16. iScience. 2022. PMID: 36065186 Free PMC article.
References
Electronic-Database Information
- GenBank, http://www.ncbi.nlm.nih.gov/Web/Genbank (for NPC1 cDNA [accession number AF002020])
- Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for NPC [257220] and Tay-Sachs disease [272800]
References
- Bowler LM, Shankaran R, Das I, Callahan JW (1990) Cholesterol esterification and Niemann-Pick disease: an approach to identifying the defect in fibroblasts. J Neurosci Res 27:505–511 - PubMed
- Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, et al (1997) Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277:228–231 - PubMed
- Ceuterick C, Martin JJ, Foulard M (1986) Niemann-Pick disease type C: skin biopsies in parents. Neuropediatrics 17:111–112 - PubMed
- Fensom AH, Grant AR, Steinberg SJ, Ward CP, Lake BD, Logan EC, Hulman G (1999) An adult with a non-neuronopathic form of Niemann-Pick C disease. J Inher Metab Dis 22:84–86 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases